Cargando…
Indications of Peptide Receptor Radionuclide Therapy (PRRT) in Gastroenteropancreatic and Pulmonary Neuroendocrine Tumors: An Updated Review
Radionuclide therapy for neuroendocrine tumors is a form of systemic radiotherapy that allows the administration of targeted radionuclides into tumor cells that express a large quantity of somatostatin receptors. The two most commonly used radio-peptides for radionuclide therapy in neuroendocrine tu...
Autores principales: | Camus, Baptiste, Cottereau, Anne-Ségolène, Palmieri, Lola-Jade, Dermine, Solène, Tenenbaum, Florence, Brezault, Catherine, Coriat, Romain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003169/ https://www.ncbi.nlm.nih.gov/pubmed/33803817 http://dx.doi.org/10.3390/jcm10061267 |
Ejemplares similares
-
Medical Treatment of Advanced Pancreatic Neuroendocrine Neoplasms
por: Palmieri, Lola-Jade, et al.
Publicado: (2020) -
Non-Pharmacological Therapeutic Options for Liver Metastases in Advanced Neuroendocrine Tumors
por: Dermine, Solène, et al.
Publicado: (2019) -
The Role of Interventional Radiology for the Treatment of Hepatic Metastases from Neuroendocrine Tumor: An Updated Review
por: Barat, Maxime, et al.
Publicado: (2020) -
Digestive Well-Differentiated Grade 3 Neuroendocrine Tumors: Current Management and Future Directions
por: Pellat, Anna, et al.
Publicado: (2021) -
Systemic therapy in metastatic pancreatic adenocarcinoma: current practice and perspectives
por: Lellouche, Lisa, et al.
Publicado: (2021)